Results 11 to 20 of about 259,455 (296)

Reducing stigma within pharmacy opioid agonist treatment encounters.

Stigma and Health
Although community pharmacies are the primary site for opioid agonist treatment (OAT) dispensing in Australia, little is known about the service experiences of consumers and pharmacists.
T. Caruana
semanticscholar   +3 more sources

Opioid Medical Detoxification Compared to Opioid Agonist Treatment during Pregnancy: A Scoping Review. [PDF]

Healthcare (Basel)
Opioid use disorder (OUD) is highly prevalent, affecting up to 1% of pregnancies. The current standard of care for the management of OUD during pregnancy has been maintained with opioid agonist treatment (OAT), using either methadone or buprenorphine. OAT use has been associated with a risk of neonatal abstinence syndrome (NAS), which requires a longer
Ordean A, DeVuono I.
europepmc   +3 more sources

What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?

European Psychiatry, 2023
Introduction Studies consistently show that patients with prescription opioid use disorder (OUD) respond to buprenorphine treatment. Few studies have followed these patients in the long-term.
R. Weiss, M. L. Griffin
doaj   +1 more source

Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis.

JAMA psychiatry, 2021
Importance Mortality among people with opioid dependence is higher than that of the general population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence; however, there has not yet been a systematic review on the ...
Thomas Santo, Brodie Clark, M. Hickman, J. Grebely, G. Campbell, L. Sordo, Aileen Z Chen, L. Tran, C. Bharat, P. Padmanathan, Gráinne Cousins, Julie Dupouy, Erin A. Kelty, R. Muga, B. Nosyk, J. Min, R. Pavarin, M. Farrell, L. Degenhardt   +18 more
semanticscholar   +1 more source

Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder

Addiction Science & Clinical Practice, 2023
Background Patients with opioid use disorder (OUD) frequently leave the hospital as patient directed discharges (PDDs) because of untreated withdrawal and pain.
A. Thakrar, Tanya J. Uritsky, C. Christopher, A. Winston, Kaitlin Ronning, Anna L. Sigueza, A. Caputo, Rachel McFadden, J. Olenik, J. Perrone, M. Delgado, M. Lowenstein, P. Compton   +12 more
semanticscholar   +1 more source

Opioid Substitution: More than Only Methadone!

European Psychiatry, 2022
Opioid misuse and its rising rates of morbidity and associated mortality is an increasing area of concern worldwide. The licit/illicit consumption of opioids ranging from plant-based substances and pharmaceutical drugs (particularly analgesia) to the new
M. Torrens
doaj   +1 more source

Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys

International Journal of Environmental Research and Public Health, 2023
Highlights OAT treatment journeys in our sample were influenced by a broad range of individual, social and structural factors, with stigma presenting a pervasive barrier to treatment retention and recovery. Pharmacies were a particularly strong source of
V. Carlisle, O. Maynard, D. Bagnall, M. Hickman, Jon Shorrock, K. Thomas, J. Kesten   +6 more
semanticscholar   +1 more source

Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada.

The International journal on drug policy, 2023
BACKGROUND Injectable opioid agonist treatment (iOAT) has recently been expanded in some geographical contexts in Canada as part of a response to the escalating overdose crisis.
Samara Mayer, Jade Boyd, N. Fairbairn, Jule Chapman, Isabella Brohman, E. Jenkins, R. McNeil   +6 more
semanticscholar   +1 more source

Alcohol use in opioid agonist treatment [PDF]

Addiction Science & Clinical Practice, 2016
Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid use disorder individually, less is known about how best ...
Nolan, Seonaid, Klimas, Jan, Wood, Evan
openaire   +4 more sources

The urgent need for opioid agonist treatment in Russia. [PDF]

Lancet HIV, 2023
Harvey L, Rybak N, Rich J.
europepmc   +3 more sources